Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments

Ann Allergy Asthma Immunol. 2022 May;128(5):595-597. doi: 10.1016/j.anai.2022.02.014. Epub 2022 Feb 25.

Authors

Mariana Bragança¹, José Luís Plácido², Luís Amaral²

Affiliations

¹ Serviço de Imunoalergologia, Centro Hospitalar Universitário de São João, Porto, Portugal. Electronic address: m_lbraganca@hotmail.com.
² Serviço de Imunoalergologia, Centro Hospitalar Universitário de São João, Porto, Portugal.

No abstract available

MeSH terms

COVID-19*
Desensitization, Immunologic
Humans
Hypersensitivity, Immediate*
Immunologic Factors
Immunotherapy
Pandemics / prevention & control
Plant Extracts

Substances

Immunologic Factors
Plant Extracts